A4GNT
protein-codingalpha-1,4-N-acetylglucosaminyltransferase, the group of Alpha 1,4-glycosyltransferases
Gene summary
This gene encodes a protein from the glycosyltransferase 32 family. The enzyme catalyzes the transfer of N-acetylglucosamine (GlcNAc) to core 2 branched O-glycans. It forms a unique glycan, GlcNAcalpha1-->4Galbeta-->R and is largely associated with the Golgi apparatus membrane. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to A4GNT variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_016161.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | ||||
| missense | 53 | 4 | 57 | |||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 54 | 5 | 0 | 59 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_057245.1 | 2 | MANE Select | |
| Ensembl | ENSP00000236709.3 | 2 | MANE Select | |
| Ensembl | ENSP00000528726.1 | 2 | Standard | |
| Ensembl | ENSP00000528726.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Post-translational protein modification
- Metabolism of proteins
- heparan sulfate biosynthesis (late stages)
- heparan sulfate biosynthesis
- O-linked glycosylation of mucins
Biological Process
- carbohydrate metabolic process
- protein O-linked glycosylation
- glycoprotein biosynthetic process
- O-glycan processing
- negative regulation of epithelial cell proliferation
Molecular Function
- acetylglucosaminyltransferase activity
Cellular Component
- Golgi membrane
- membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000236709
- Coding exons
- 2
- Length
- 8670
- Individuals with no LoFs
- 125110
- Homozygous LoFs
- 3
- Heterozygous LoFs
- 635
- Defined
- 125748
- p
- 0.00254
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.235 | 179 | 188 | 0.952 | 0.0000101 | 2239 |
| Missense (PolyPhen) | 50 | 57.242 | 0.87349 | 713 | ||
| Synonymous | -0.234 | 77 | 74.4 | 1.03 | 0.00000402 | 659 |
| Loss of Function | 2.14 | 3 | 10.5 | 0.286 | 4.48e-7 | 131 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00068 | 0.00068 | rare |
| Latino/Admixed American | 0.0013 | 0.0013 | notable |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.0094 | 0.0094 | notable |
| European (Non-Finnish) | 0.0032 | 0.0032 | notable |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.0018 | 0.0018 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the transfer of N-acetylglucosamine (GlcNAc) to core 2 branched O-glycans (PubMed:10430883). Necessary for the synthesis of type III mucin which is specifically produced in the stomach, duodenum, and pancreatic duct (PubMed:10430883). May protect against inflammation-associated gastric adenocarcinomas (By similarity). {ECO:0000250|UniProtKB:Q14BT6, ECO:0000269|PubMed:10430883}.;
Recessive Scores
- pRec
- 0.0885
Intolerance Scores
- LoFtool
- 0.260
- RVIS EVS
- 1.11
- RVIS percentile EVS
- 92.04
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.148
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |